Attenuation of anticipation: A therapeutic use of lysergic acid diethylamide
The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“After LSD treatment, patients experienced less pain, a better mood, more positive attitudes towards life, and less illness-and death-related distress (1967).”
From Psychedelics for the treatment of depression, anxiety, and existential distress in patients with a terminal illness: a systematic review (2022) · cites this paper as Kast, 1967
Citations
Cites
Huxley, A. (1954) · Cited by 415
Study of Lysergic Acid Diethylamide as an Analgesic Agent
KAST, E. C., & COLLINS, V. J. (1964) · Anesthesia & Analgesia · doi:10.1213/00000539-196405000-00013 · Cited by 142
Self-citationPharmacotherapeutic Evaluation and the Psychiatric Setting
Sabshin, M. (1956) · Archives of Neurology And Psychiatry · doi:10.1001/archneurpsyc.1956.02330220026003 · Cited by 46
The Measurement of Pain: A New Approach to an Old Problem
Kast, E. C. (1962) · The Journal of New Drugs · doi:10.1177/009127006200200604 · Cited by 15
Self-citationA Theory of Human Pathologic Pain and Its Measurement: The Analgesic Activity of Methotrimeprazine
Kast, E. C., & Collins, V. J. (1966) · The Journal of New Drugs · doi:10.1177/009127006600600303 · Cited by 8
Self-citationPharmacologic advances in psychiatry.
Malitz, S. (1957) · PubMed · Cited by 1
Kuromaru, S., Okada, S., HANADA, M., KASAHARA, Y., & Sakamoto, K. (1962) · PubMed · Cited by 1
Research works printed but not linked: 1
- Pavlov, I.: Lectures on the Conditioned Reflex. International Publishers. New York. 1928.
Cited by
Griffiths, R. R., Johnson, M. W., Carducci, M. A., Umbricht, A., Richards, W. A., Richards, B. D., Cosimano, M. P., & Klinedinst, M. A. (2016) · Journal of Psychopharmacology · doi:10.1177/0269881116675513 · Cited by 2,201
“Several unblinded studies in the 1960s and 70s suggested that such compounds might be effective in treating psychological distress in cancer patients (Grof et al., 1973; Kast, 1967; Richards et al., 1977); however, these studies did not include the comparison conditions that would be expected of modern psychopharmacol…”
BackgroundHuman hallucinogen research: guidelines for safety
Johnson, M., Richards, W., & Griffiths, R. (2008) · Journal of Psychopharmacology · doi:10.1177/0269881108093587 · Cited by 1,203
“Anecdotal observations and non-blind studies in cancer patients suffering from anxiety and depression suggested that LSD administration resulted in an ability to openly discuss existential fears and be at peace with approaching death, and that this reorientation often outlasted the acute drug effects (Kast and Collins…”
BackgroundPsilocybin occasioned mystical-type experiences: immediate and persisting dose-related effects
Griffiths, R. R., Johnson, M. W., Richards, W. A., Richards, B. D., McCann, U., & Jesse, R. (2011) · Psychopharmacology · doi:10.1007/s00213-011-2358-5 · Cited by 932
“This effect may be relevant to the proposed palliative effects of psilocybin and similar hallucinogens in treating existential anxiety in terminal illness (Kast 1967; Richards et al. 1972; Grob et al. 2011).”
BackgroundMacLean, K. A., Johnson, M. W., & Griffiths, R. R. (2011) · Journal of Psychopharmacology · doi:10.1177/0269881111420188 · Cited by 895
“Clinical work along these lines was initiated in the 1950s and suggested possible improvements after hallucinogen treatment in individuals with terminal cancer (Grob et al., 2011; Kast, 1967; Richards et al., 1977) and substance dependence (Halpern, 1996; Mangini, 1998; Terrill et al.”
Johnson, M. W., Hendricks, P. S., Barrett, F. S., & Griffiths, R. R. (2019) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2018.11.010 · Cited by 506
Hartogsohn, I. (2016) · Journal of Psychopharmacology · doi:10.1177/0269881116677852 · Cited by 483
“In the 1960s, LSD was demonstrated to be effective in the alleviation of pain (Kast et al., 1964; Kast, 1967).”
BackgroundGasser, P., Kirchner, K., & Passie, T. (2015) · Journal of Psychopharmacology · doi:10.1177/0269881114555249 · Cited by 456
Potential Therapeutic Effects of Psilocybin
Johnson, M. W., & Griffiths, R. R. (2017) · Neurotherapeutics · doi:10.1007/s13311-017-0542-y · Cited by 296
Majić, T., Schmidt, T. T., & Gallinat, J. (2015) · Journal of Psychopharmacology · doi:10.1177/0269881114568040 · Cited by 261
“…had focused primarily on analgesia, and psychotherapeutic preparation or follow-up had not been conducted, they reported patients having gained profound insight and a changed attitude towards the self and their social surroundings, which alleviated their anxiety towards dying (Kast, 1966, 1967).”
BackgroundResultInfluentialClassical psychedelics for the treatment of depression and anxiety: A systematic review
Muttoni, S., Ardissino, M., & John, C. (2019) · Journal of Affective Disorders · doi:10.1016/j.jad.2019.07.076 · Cited by 256
dos Santos, R. G., Bouso, J. C., Alcázar-Córcoles, M. Á., & Hallak, J. E. C. (2018) · Expert Review of Clinical Pharmacology · doi:10.1080/17512433.2018.1511424 · Cited by 227
Garcia-Romeu, A., & Richards, W. A. (2018) · International Review of Psychiatry · doi:10.1080/09540261.2018.1486289 · Cited by 189
Psychedelic-Assisted Psychotherapy—A Systematic Review of Associated Psychological Interventions
Cavarra, M., Falzone, A., Ramaekers, J. G., Kuypers, K. P. C., & Mento, C. (2022) · Frontiers in Psychology · doi:10.3389/fpsyg.2022.887255 · Cited by 171
“, 1963), alcoholism (Smith, 1958; Leuner, 1967), end-of-life anxiety (Kast, 1967; Grof et al., 1973; Grof and Halifax, 1978), and chronic pain (Fanciullacci et al.”
BackgroundSchimmers, N., Breeksema, J. J., Smith-Apeldoorn, S. Y., Veraart, J., van den Brink, W., & Schoevers, R. A. (2022) · Psychopharmacology · doi:10.1007/s00213-021-06027-y · Cited by 162
Yao, Y., Guo, D., Lu, T., Liu, F.-L., Huang, S., Diao, M.-Q., Li, S., Zhang, X.-J., Kosten, T. R., Shi, J., et al. (2024) · Psychiatry Research · doi:10.1016/j.psychres.2024.115886 · Cited by 174
“…D ’ Souza et al., 2022; Dominguez-Clave et al., 2019; Doss et al., 2021; Gouzou-lis-Mayfrank et al., 2005; Grof et al., 1973; Johnson et al., 2014; Kast, 1967; Kast and Collins, 1964; Moreno et al., 2006; Nicholas et al., 2022; Pahnke et al., 1969; Roseman et al., 2018; Schindler et al., 2021,…”
Ross, S., Agin-Liebes, G., Lo, S., Zeifman, R. J., Ghazal, L., Benville, J., Franco Corso, S., Bjerre Real, C., Guss, J., Bossis, A., et al. (2021) · ACS Pharmacology & Translational Science · doi:10.1021/acsptsci.1c00020 · Cited by 139
Reiche, S., Hermle, L., Gutwinski, S., Jungaberle, H., Gasser, P., & Majić, T. (2018) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2017.09.012 · Cited by 122
“…the analgesic actions of LSD: most importantly, Kast proposed the concept of ‘attenuation of anticipation’, in which he suggested that patients benefit from ‘the loss of the ability to anticipate’ pain and death, at the same time experiencing an ‘expansion of immediate sensory life’ (Kast, 1967).”
BackgroundMethodInfluentialTherapeutic use of classic psychedelics to treat cancer-related psychiatric distress
Ross, S. (2018) · International Review of Psychiatry · doi:10.1080/09540261.2018.1482261 · Cited by 102
“This set the stage for Kast to treat several hundred more patients with terminal cancer (paying more attention to the unique psychological effects of LSD) and reported on improvements in depression and fear of death, and the induction of mystical states of consciousness (Kast, 1966; 1967).”
InfluentialWhy was early therapeutic research on psychedelic drugs abandoned?
Hall, W. (2022) · Psychological Medicine · doi:10.1017/s0033291721004207 · Cited by 86
“…reported 70% improvement in symptoms in neurotic disorders (e.g. Cohen & Eisner, 1959) and investigators later reported that LSD substantially reduced anxiety and distress in patients who had terminal cancer (e.g. Kast, 1966, 1967; Pahnke, Kurland, Unger, Savage, & Grof, 1970; Ross, 2018).”
BackgroundA low dose of lysergic acid diethylamide decreases pain perception in healthy volunteers
Ramaekers, J. G., Hutten, N., Mason, N. L., Dolder, P., Theunissen, E. L., Holze, F., Liechti, M. E., Feilding, A., & Kuypers, K. P. (2021) · Journal of Psychopharmacology · doi:10.1177/0269881120940937 · Cited by 92
Leonard, J. B., Anderson, B., & Klein-Schwartz, W. (2018) · Journal of Psychopharmacology · doi:10.1177/0269881118793086 · Cited by 88
Schindler, E. A. D., Sewell, R. A., Gottschalk, C. H., Luddy, C., Flynn, L. T., Zhu, Y., Lindsey, H. M., Pittman, B. P., Cozzi, N. V., & D’Souza, D. C. (2022) · Headache The Journal of Head and Face Pain · doi:10.1111/head.14420 · Cited by 91
Ross, S., Agrawal, M., Griffiths, R. R., Grob, C. S., Berger, A. M., & Henningfield, J. E. (2022) · Neuropharmacology · doi:10.1016/j.neuropharm.2022.109174 · Cited by 81
Maia, L. O., Beaussant, Y., & Garcia, A. C. M. (2022) · Journal of Pain and Symptom Management · doi:10.1016/j.jpainsymman.2022.01.024 · Cited by 60
Schindler, E. A. D., Wallace, R. M., Sloshower, J. A., & D’Souza, D. C. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.00177 · Cited by 47
“…that psychedelics may delay the onset and reduce total duration of REM sleep (Hobson, 1964; Depoortere and Loew, 1971; Brooks, 1975; Kay and Martin, 1978) might suggest that one of their therapeutic benefits in cluster headache stems from manipulation of the sleep period during which…”
BackgroundInfluentialWhelan, A., & Johnson, M. I. (2018) · Pain Management · doi:10.2217/pmt-2017-0068 · Cited by 51
Bornemann, J., Close, J. B., Spriggs, M. J., Carhart-Harris, R. L., & Roseman, L. (2021) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2021.735427 · Cited by 53
Are psychedelics the answer to chronic pain: A review of current literature
Kooijman, N. I., Willegers, T., Reuser, A. M., Mulleners, W. M., Kramers, C., Vissers, K. C. P., & van der Wal, S. E. I. (2023) · Pain Practice · doi:10.1111/papr.13203 · Cited by 52
“Patients also experienced some mild visual distortions or mild hallucinations and anxiety.(54) These psychological factors became the primary focus of research involving psychedelic treatment in cancer patients.”
BackgroundThe History of Psychedelics in Medicine
Sessa, B. (2016) · Springer eBooks · doi:10.1007/978-3-642-55214-4_96-1 · Cited by 65
“Chicago psychiatrist Eric Kast shows that LSD given at sub-psychedelic doses without formal psychotherapy out-performs traditional opiate-based drugs for relieving pain and anxiety for patients with end-stage cancer (Kast 1967).”
BackgroundBeaussant, Y., Sanders, J. J., Sager, Z. S., Tulsky, J. A., Braun, I. M., Blinderman, C. D., Bossis, A. P., & Byock, I. R. (2020) · Journal of Palliative Medicine · doi:10.1089/jpm.2019.0603 · Cited by 48
Halpern, J. H. (2003) · Current Psychiatry Reports · doi:10.1007/s11920-003-0067-4 · Cited by 44
Mapping an Agenda for Psychedelic-Assisted Therapy Research in Patients with Serious Illness
Beaussant, Y., Tulsky, J. A., Guérin, B., Schwarz-Plaschg, C. G., Sanders, J. J., Beaussant, Y., Sanders, J. J., Guérin, B., Schwarz-Plaschg, C. G., Agrawal, M., et al. (2021) · Journal of Palliative Medicine · doi:10.1089/jpm.2020.0764 · Cited by 41
Reynolds, L., Akroyd, A., Sundram, F., Stack, A., Muthukumaraswamy, S. D., & Evans, W. J. (2021) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph18158160 · Cited by 39
The Potential of Psychedelics for End of Life and Palliative Care
Yaden, D. B., Nayak, S. M., Gukasyan, N., Anderson, B. T., & Griffiths, R. R. (2021) · Current topics in behavioral neurosciences · doi:10.1007/7854_2021_278 · Cited by 39
Use of Psychedelics for Pain: A Scoping Review
Goel, A., Rai, Y., Sivadas, S., Diep, C., Clarke, H. A., Shanthanna, H., & Ladha, K. S. (2023) · Anesthesiology · doi:10.1097/aln.0000000000004673 · Cited by 38
Are psychedelic medicines the reset for chronic pain? Preliminary findings and research needs
Zia, F. Z., Baumann, M. H., Belouin, S. J., Dworkin, R. H., Ghauri, M. H., Hendricks, P. S., Henningfield, J. E., Lanier, R. K., Ross, S., & Berger, A. M. (2023) · Neuropharmacology · doi:10.1016/j.neuropharm.2023.109528 · Cited by 34
“…into the investigation of the beneficial effects of psychedelics for the management of anxiety and chronic pain in patients with terminal illness dates back to the 1960’s. Kast (1967) reported analgesic benefits of LSD (100 μg po) in a series of 128 patients, receiving end-of-life palliative care.”
BackgroundPotential analgesic effects of psychedelics on select chronic pain conditions: A survey study
Cavarra, M., Mason, N., Kuypers, K., Bonnelle, V., Smith, W. J., Feilding, A., Kryskow, P., & Ramaekers, J. (2023) · European Journal of Pain · doi:10.1002/ejp.2171 · Cited by 26
“The present results are in line with what was suggested by early research in the field (Fanciullacci et al., 1977; Grof et al., 1973; Kast, 1967; Kast & Collins, 1963), recent experimental studies on healthy volunteers (Ramaekers et al., 2021), survey studies focussing on headache disorders…”
BackgroundResultPsychedelics as preventive treatment in headache and chronic pain disorders
Schindler, E. A. D. (2022) · Neuropharmacology · doi:10.1016/j.neuropharm.2022.109166 · Cited by 31
Silverman, J. (1971) · Archives of General Psychiatry · doi:10.1001/archpsyc.1971.01750180018004 · Cited by 28
A rapid narrative review of the clinical evolution of psychedelic treatment in clinical trials
Kishon, R., Modlin, N. L., Cycowicz, Y. M., Mourtada, H., Wilson, T., Williamson, V., Cleare, A. J., & Rucker, J. (2024) · npj Mental Health Research · doi:10.1038/s44184-024-00068-9 · Cited by 33
“” 11 This approach emphasized the utility of patients ’ courage, willingness to surrender to the drug effects, self-acceptance, and responsibility for change 59 .”
(2024) · doi:10.1177/02698811231215420 · Cited by 25
“…2020; Oehen et al., 2013; Ot’alora et al., 2018; Wolfson et al., 2020), eight used LSD (Gasser et al., 2014; Grof et al., 1972; Holze et al., 2022; Kast, 1967; Kurland et al., 1971; Mccabe et al., 1972; Pahnke et al., 1969; Savage and McCabe, 1973), three used ayahuasca (Osorio et al., 2015;…”
MethodResultInfluentialMacrodosing to microdosing with psychedelics: Clinical, social, and cultural perspectives
Kaypak, A. C., & Raz, A. (2022) · Transcultural Psychiatry · doi:10.1177/13634615221119386 · Cited by 24
Dworkin, R. H., Anderson, B. T., Andrews, N., Edwards, R. R., Grob, C. S., Ross, S., Satterthwaite, T. D., & Strain, E. C. (2022) · Journal of Pain · doi:10.1016/j.jpain.2022.05.003 · Cited by 27
Psychedelics in the Treatment of Headache and Chronic Pain Disorders
Schindler, E. A. D. (2022) · Current topics in behavioral neurosciences · doi:10.1007/7854_2022_365 · Cited by 20
Human behavioral pharmacology of psychedelics
Strickland, J. C., & Johnson, M. W. (2022) · Advances in pharmacology · doi:10.1016/bs.apha.2021.10.003 · Cited by 16
Study protocol for “Psilocybin in patients with fibromyalgia: brain biomarkers of action”
Bornemann, J., Close, J. B., Ahmad, K., Barba, T., Godfrey, K., Macdonald, L., Erritzøe, D., Nutt, D. J., & Carhart-Harris, R. L. (2024) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2024.1320780 · Cited by 16
Some Compounds With Hallucinogenic Activity
Fanchamps, A. (1978) · Springer eBooks · doi:10.1007/978-3-642-66775-6_8 · Cited by 15
Pain and Perception: Exploring Psychedelics as Novel Therapeutic Agents in Chronic Pain Management
Strand, N. H., Whitney, M. A., Johnson, B. W., Dunn, T., Attanti, S., Maloney, J. A., Misra, L., Gomez, D., Viswanath, O., Emami, E., et al. (2025) · Current Pain and Headache Reports · doi:10.1007/s11916-024-01353-0 · Cited by 15
“A subsequent study showed that a single dose of LSD sig - nificantly reduced pain scores for up to two weeks in termi - nally ill cancer patients [57].”
Classic Psychedelics in Pain Modulation: Mechanisms, Clinical Evidence, and Future Perspectives
Czopek, A., Jończyk, J., Fryc, M., Kluzik, D., & Zagórska, A. (2025) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.5c00152 · Cited by 14
“83 Over the past decade, classic psychedelics have been extensively researched for their potential to treat chronic pain, as evidenced by population-based studies, case reports, and clinical trials described below.”
Weleff, J., Nunes, J. C., Costa, G. P. A., Sofuoglu, M., MacLean, R. R., & Aquino, J. P. D. (2024) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.16045 · Cited by 15
“82 Among the 128 participants included in this study, a fraction had various forms of metastatic cancer (i.e., breast, cervical, lung, larynx and pancreatic cancer).”
Classic psychedelics as therapeutics for psychiatric disorders
Nichols, C. D., & Hendricks, P. S. (2020) · Handbook of behavioral neuroscience · doi:10.1016/b978-0-444-64125-0.00049-9 · Cited by 12
Sholevar, R., Peteet, J. R., Sanders, J. J., & Beaussant, Y. (2023) · Palliative & Supportive Care · doi:10.1017/s1478951523001475 · Cited by 10
Wells, A., Muthukumaraswamy, A. P. S., Morunga, E., Evans, W., Cavadino, A., Bansal, M., Lawrence, N. J., Ashley, A., Hoeh, N. R., Sundram, F., et al. (2024) · Pilot and Feasibility Studies · doi:10.1186/s40814-024-01449-9 · Cited by 12
Rational Suicide in the Elderly
Balasubramaniam, M., & McCue, R. E. (2016) · Springer eBooks · doi:10.1007/978-3-319-32672-6 · Cited by 10
Adapting psychedelic medicine for headache and chronic pain disorders
Schindler, E. A. D., & Hendricks, P. S. (2023) · Expert Review of Neurotherapeutics · doi:10.1080/14737175.2023.2246655 · Cited by 9
Korman, B. A. (2023) · Journal of Psychedelic Studies · doi:10.1556/2054.2023.00246 · Cited by 7
“Another possibility as to why the findings of this study do not align with those linking classic psychedelic use to better mental health outcomes during the COVID-19 pandemic is that classic psychedelics have been noted to ease one’s fear of death (Grof, Goodman, Richards, & Kurland, 1973; Kast, 1967), a fear fed by t…”
ResultPilot study of psilocybin in patients with post-treatment lyme disease
Garcia‐Romeu, A., Naudé, G. P., Rebman, A. W., So, S., Yaffe, A., Geithner, I., Kozero, E. A., Yang, T., Soloski, M. J., & Aucott, J. N. (2026) · Scientific Reports · doi:10.1038/s41598-026-38091-9 · Cited by 6
Best Practices in Caring for Seriously Ill Patients
Bernacki, R., & Periyakoil, V. S. (2024) · Annals of Internal Medicine · doi:10.7326/aitc202407160 · Cited by 7
Gold, N. D., Mallard, A. J., Hermann, J. C., Zeifman, R. J., Pagni, B. A., Bogenschutz, M. P., & Ross, S. (2023) · Journal of Palliative Medicine · doi:10.1089/jpm.2022.0604 · Cited by 6
Lifetime classic psychedelic use and headaches: A cross-sectional study
Bjurenfalk, Z., Cosmo, A., Simonsson, O., & Ran, C. (2025) · Journal of Psychopharmacology · doi:10.1177/02698811251324372 · Cited by 5
“Preliminary findings from the 1960s suggested that classic psychedelic substances might have a role in treating headache disorders (Kast, 1967; Sicuteri, 1963).”
History of psychedelic drug science and molecular pharmacology
Nichols, D. E., & Nichols, C. D. (2025) · International review of neurobiology · doi:10.1016/bs.irn.2025.02.001 · Cited by 7
Using Psychedelics in Clinical Practice: Comparing Therapeutic Uses and Potential Harms
Tariq, R. (2022) · Current Clinical Pharmacology · doi:10.2174/2772432817666220321142707 · Cited by 5
Psychedelics for the treatment of end-of-life distress in patients with a life-threatening disease
Tap, S. C., Bostoen, T., Breeksema, J. J., & Schoevers, R. A. (2025) · International review of neurobiology · doi:10.1016/bs.irn.2025.03.001 · Cited by 4
LSD et soins palliatifs dans les années 1960, un rendez-vous manqué ?
Dubus, Z. (2021) · Médecine Palliative · doi:10.1016/j.medpal.2020.10.002 · Cited by 4
Walt, J. V. D., & Parker, R. (2023) · South African Medical Journal · doi:10.7196/samj.2023.v113i11.814 · Cited by 5
Gold, N. D., Podrebarac, S. K., White, L. A., Marini, C., Simon, N. M., Mittelman, M. S., Ross, S., Bogenschutz, M. P., & Petridis, P. D. (2023) · Psychedelic Medicine · doi:10.1089/psymed.2022.0011 · Cited by 3
“45 During the 1950s and 1960s, an estimated tens of thousands of patients were treated with psychedelic therapy 45,46 for a variety of clinical conditions, including alcohol use disorder, 47 existential distress in advanced cancer, 48,49 pain, 50 and more.”
Oña, G. (2023) · Quaderns de l'Institut Català d'Antropologia · doi:10.56247/qua.401 · Cited by 4
Hendricks, P. S., & Grob, C. S. (2016) · Springer eBooks · doi:10.1007/978-3-319-32672-6_14 · Cited by 3
Shey, H. H. (1971) · Psychiatric Quarterly · doi:10.1007/bf01574275 · Cited by 3
Barta, S., Brooker, J., & O’Callaghan, C. C. (2024) · Journal of Palliative Medicine · doi:10.1089/jpm.2024.0306 · Cited by 3
“10 Similar positive results were found in further early phase (1960s to early 1970s) studies 11 ; however, due to sociopolitical factors, psychedelic substances were banned under the United States Controlled Substances Act 1971, 12 effectively halting research for approximately three decades.”
A scoping review of the effects of serotonergic psychedelics on attitudes towards death
Barr, N. N. T., Giese, K. J., & Moreton, S. G. (2025) · Psychopharmacology · doi:10.1007/s00213-025-06787-x · Cited by 3
Psilocybin as a psychophysical adaptogen in chronic pain rehabilitation
Cherup, N. P., & Finan, P. H. (2025) · Journal of Pain · doi:10.1016/j.jpain.2025.105507 · Cited by 2
Garcia, A. C. M., Teixeira, F., & Maia, L. O. (2025) · Journal of Holistic Nursing · doi:10.1177/08980101251374371 · Cited by 3
“These studies laid the groundwork for today's interest in psychedelic-assisted therapies, suggesting that LSD and other substances could play a signi fi cant role in relieving existential suffering at the end of life (Kast, 1966, 1967).”
Kratina, S., Strıke, C., Schwartz, R. D., Nayfeh, A., Jopling, S. A., Lo, C., & Rush, B. R. (2025) · Social Science & Medicine · doi:10.1016/j.socscimed.2025.118536 · Cited by 2
Psychedelic-Assisted Therapy in Palliative Care—Insights from an International Workshop
Schuldt, A., Clark, I. C., Schmid, Y., Ljuslin, M., Boehlke, C. S., Schipper, S., Sands, M. B., & Blum, D. (2025) · Healthcare · doi:10.3390/healthcare13182275 · Cited by 4
Kazdan, J., Ladha, K. S., & Husain, M. I. (2026) · Pharmacology Research & Perspectives · doi:10.1002/prp2.70238 · Cited by 2
Barco, J. A. V., & Garcia, A. C. M. (2025) · Progress in Palliative Care · doi:10.1080/09699260.2025.2484066 · Cited by 2
Lysergic Acid Diethylamide as an Analgesic Agent in Patients with Terminal Illnesses
Das, S., & Maiti, T. (2019) · Pain Management · doi:10.2217/pmt-2019-0043 · Cited by 2
Cavarra, M., Hutten, N. R. P. W., Schepers, J., Mason, N. L., Theunissen, E. L., Liechti, M. E., Kuypers, K. P. C., Bonnelle, V., Feilding, A., & Ramaekers, J. G. (2025) · British Journal of Pain · doi:10.1177/20494637251371626 · Cited by 1
Barnett, B. S., Anand, A., Weleff, J., King, F., & Dewey, E. N. (2025) · Psychedelic Medicine · doi:10.1177/28314425251367321 · Cited by 1
“33 40 In one case series of 36 patients with various conditions, one participant refused further LSD doses after their fi rst treatment.”
Could Psychedelics Treat Neuropathic Chronic Pain?
(2023) · Neurological Sciences and Neurosurgery · doi:10.47275/2692-093x-130 · Cited by 1
“Kast E (1966) [64], Kast E (1966) [65], published two studies describing the administration of LSD to patients with painful and terminal conditions, mostly cancer.”
BackgroundPsychedelic-assisted therapies for existential and spiritual suffering in palliative care
Garcia, A. C. M., & Maia, L. O. (2025) · Progress in brain research · doi:10.1016/bs.pbr.2025.07.002 · Cited by 1
Psychedelic therapy from an existential psychological viewpoint : a theoretical analysis
Berg, S. H. (2016) · NORA - Norwegian Open Research Archives
Geschichte der Psychedelika in der Medizin
Sessa, B. (2017) · Springer eBooks · doi:10.1007/978-3-642-55125-3_99 · Cited by 1
Psycholytische Therapie. Leben wollen und sterben können
Gasser, P. (2017) · Vandenhoeck & Ruprecht eBooks · doi:10.13109/9783666402883.311
Geschichte der Psychedelika in der Medizin
Sessa, B. (2017) · Springer eBooks · doi:10.1007/978-3-642-55214-4_99-1
Psilocybin-Assisted Psychotherapy in Palliative Care
Ross, S., & Bossis, A. P. (2022) · Oxford University Press eBooks · doi:10.1093/med/9780197583838.003.0042
Breeksema, J. J. (2024) · University of Groningen research database (University of Groningen / Centre for Information Technology) · doi:10.33612/diss.912040905 · Cited by 1
Psychedelia in the United States: An Ethnographic Study of Naturalistic Psychedelic Use
Seikel, T. S. (2020) · University of North Texas Digital Library (University of North Texas) · doi:10.12794/metadc1752384
Lerner, Z. I., Liu, J. C., Thielking, P. D., & Luce, D. (2025) · Oxford University Press eBooks · doi:10.1093/med/9780197760864.003.0004
Wells, A., Muthukumaraswamy, A. P. S., Morunga, E., Evans, W., Cavadino, A., Bansal, M., Lawrence, N. J., Ashley, A., Hoeh, N. R., Sundram, F., et al. (2024) · Figshare · doi:10.6084/m9.figshare.25210532
Wells, A., Muthukumaraswamy, A. P. S., Morunga, E., Evans, W., Cavadino, A., Bansal, M., Lawrence, N. J., Ashley, A., Hoeh, N. R., Sundram, F., et al. (2024) · Figshare · doi:10.6084/m9.figshare.25210812
Hurwitz, E. S. (2024) · eScholarship (California Digital Library) · Cited by 4
Bisson, M. D. (2023) · Papyrus : Institutional Repository (Université de Montréal) · doi:10.71781/18057
Exploring associations between connectedness and death anxiety following a psychedelic experience
Barr, N. N. T., Larance, B., Schweickle, M. J., & Moreton, S. G. (2026) · Journal of Psychedelic Studies · doi:10.1556/2054.2026.00477
Dubus, Z. (2022) · theses.fr (ABES) · doi:10.70675/27f3349cz9072z4b1dzbe45z1dedd80e5d18 · Cited by 2
ARNISON, C. (2025) · Otago University Research Archive (University of Otago)
Metadata
- Authors
- Kast, E.
- Corresponding author
- Kast, Eric
- Venue
- The Psychiatric Quarterly
- Published
- 1967-10
- Volume
- 41
- Issue
- 4
- Pages
- 646-657
- ISSN
- 0033-2720 (ISSN-L)
- 1573-6709
- OpenAlex
- W2031343230
- Cited by
- 94
- References
- 7
- Citations by year
- 2026: 3 · 2025: 15 · 2024: 11 · 2023: 12 · 2022: 12 · 2021: 8 · 2020: 4 · 2019: 3 · 2018: 7 · 2017: 5 · 2016: 5 · 2015: 1 · 2014: 1
- FWCI
- 0.00
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Psychiatric Quarterly (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Social Sciences › Psychology › Clinical Psychology › Psychedelics and Drug Studies
- Life Sciences › Neuroscience › Cognitive Neuroscience › Pain Management and Placebo Effect
- Health Sciences › Medicine › Anesthesiology and Pain Medicine › Pain Management and Opioid Use
- Keywords
- lysergic acid diethylamide, LSD, analgesia, drug safety, psychedelic therapy
- MeSH terms
- Affect, Analgesics, Attitude, Fear, Hallucinations, Humans, Lysergic Acid Diethylamide, Middle Aged, Neoplasms, Palliative Care, Perception, Sleep
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.